Jiya Acquisition, a blank check company formed by Samsara BioCapital targeting the biopharmaceutical sector, raised $100 million by offering 10 million shares at $10. Unlike an ordinary SPAC, Jiya Acquisition did not offer units with warrants attached. The...read more
Just one SPAC priced this past week in the wake of the US presidential election. Despite uncertain results, the IPO market bounced back from the previous week’s downturn, with the IPO Index gaining 12.5%. New filings trickled in, priming the pipeline for...read more
Jiya Acquisition, a blank check company formed by Samsara BioCapital targeting the biopharmaceutical sector, filed on Monday with the SEC to raise up to $100 million in an initial public offering.
The Palo Alto, CA-based company plans to raise $100 million ...read more
Samsara BioCapital's biopharma SPAC Jiya Acquisition prices $100 million IPO at $10
Jiya Acquisition, a blank check company formed by Samsara BioCapital targeting the biopharmaceutical sector, raised $100 million by offering 10 million shares at $10. Unlike an ordinary SPAC, Jiya Acquisition did not offer units with warrants attached. The...read more
US IPO Weekly Recap: The IPO market takes a break during election week
Just one SPAC priced this past week in the wake of the US presidential election. Despite uncertain results, the IPO market bounced back from the previous week’s downturn, with the IPO Index gaining 12.5%. New filings trickled in, priming the pipeline for...read more
Samsara BioCapital's biopharma SPAC Jiya Acquisition files for a $100 million IPO
Jiya Acquisition, a blank check company formed by Samsara BioCapital targeting the biopharmaceutical sector, filed on Monday with the SEC to raise up to $100 million in an initial public offering. The Palo Alto, CA-based company plans to raise $100 million ...read more